<DOC>
	<DOCNO>NCT00063622</DOCNO>
	<brief_summary>The purpose study determine therapy pioglitazone vitamin E lead improvement liver histology non-diabetic adult patient non-alcoholic steatohepatitis ( NASH ) .</brief_summary>
	<brief_title>Pioglitazone v Vitamin E v Placebo Treatment Non-Diabetic Patients With Nonalcoholic Steatohepatitis ( PIVENS )</brief_title>
	<detailed_description>The purpose study determine therapy pioglitazone vitamin E lead improvement liver histology non-diabetic adult patient non-alcoholic steatohepatitis ( NASH ) .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Fatty Liver</mesh_term>
	<mesh_term>Non-alcoholic Fatty Liver Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin E</mesh_term>
	<mesh_term>Tocopherols</mesh_term>
	<mesh_term>Tocotrienols</mesh_term>
	<mesh_term>alpha-Tocopherol</mesh_term>
	<mesh_term>Pioglitazone</mesh_term>
	<criteria>Histologic evidence NASH base liver biopsy obtain within 6 month randomization . Age 18 year old</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2012</verification_date>
	<keyword>Non alcoholic steatohepatitis</keyword>
	<keyword>Steatohepatitis</keyword>
</DOC>